Your browser doesn't support javascript.
loading
Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.
Liu, Zheng; Julsgaard, Mette; Zhu, Xiao; Martin, Jennifer; Barclay, Murray L; Cranswick, Noel; Gibson, Peter R; Gearry, Richard B; van der Giessen, Janine; Connor, Susan J; Rosella, Ourania; Grosen, Anne; Toong, Catherine; Flanagan, Emma; Wieringa, Jantien W; Janneke van der Woude, C; Bell, Sally J.
Afiliación
  • Liu Z; Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Hunter Medical Research Institute, Kookaburra Circuit, Australia.
  • Julsgaard M; Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital Melbourne, Australia.
  • Zhu X; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Martin J; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Barclay ML; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Cranswick N; Department of Gastroenterology, St Vincent's Hospital, and University of Melbourne, Melbourne, Australia.
  • Gibson PR; Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, China.
  • Gearry RB; School of Pharmacy, University of Otago, Dunedin, New Zealand.
  • van der Giessen J; Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Hunter Medical Research Institute, Kookaburra Circuit, Australia.
  • Connor SJ; Departments of Gastroenterology & Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand.
  • Rosella O; Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital Melbourne, Australia.
  • Grosen A; Department of Gastroenterology, Alfred Hospital, and Monash University, Melbourne, VIC, Australia.
  • Toong C; Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Flanagan E; Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Wieringa JW; Department of Gastroenterology, Liverpool Hospital, Sydney.
  • Janneke van der Woude C; South Western Sydney Clinical, University of NSW Sydney.
  • Bell SJ; Ingham Institute of Applied Medical Research, Sydney, Australia.
J Crohns Colitis ; 16(12): 1835-1844, 2022 Dec 05.
Article en En | MEDLINE | ID: mdl-35779236
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Atenuadas / Enfermedades Inflamatorias del Intestino / Adalimumab / Infliximab Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: J Crohns Colitis Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Atenuadas / Enfermedades Inflamatorias del Intestino / Adalimumab / Infliximab Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: J Crohns Colitis Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido